The WHO also warned of the risk of flare-ups due to ligering virus in some survivors, a threat it says will decline with time.
Experts called together in the wake of the Ebola crisis laid out ways to better prepare for the next threat.
Johnson & Johnson's prime-boost Ebola vaccine regimen is entering phase 2 clinical trials in both healthy and HIV-infected people, the Walter Reed Army Institute of Research (WRAIR) announced yesterday in a press release.
Also, a short report notes gender differences during the outbreak, such as higher survival in females.
Social networks, though, were strong in poorer areas, which helped with disease control.
Forty-two days (two incubation periods) after its last Ebola patient tested negative for the virus, Guinea has been declared Ebola-free by the World Health Organization (WHO), leaving only Liberia to achieve that status in the outbreak region of West Africa, the WHO said in a news release.
After going 9 days without reporting a MERS-CoV infection, Saudi Arabia's Ministry of Health (MOH) confirmed a case yesterday.
Researchers used detailed exams in survivors to document eye problems, a common finding.
The World Health Organization (WHO) said that Ebola virus infection in West Africa continues to constitute a Public Health Emergency of International Concern (PHEIC), largely due to the potential for transmission of the virus from survivors and convalescent populations, according to a Dec 18 statement.
The Centers for Disease Control and Prevention (CDC) is now investigating two separate Escherichia coli outbreaks tied to Chipotle restaurants, one involving 53 cases and the other 5, the agency said today in an update.
